位置:成果数据库 > 期刊 > 期刊详情页
α1-肾上腺素受体激活大鼠心脏腺苷酸活化蛋白激酶
  • ISSN号:0371-0874
  • 期刊名称:《生理学报》
  • 时间:0
  • 分类:Q591[生物学—生物化学] R318.11[医药卫生—生物医学工程;医药卫生—基础医学]
  • 作者机构:[1]北京大学第三医院血管医学研究所,分子心血管教育部重点实验室,北京100083, [2]北京大学生命科学学院,生物膜与膜生物工程国家重点实验室,北京100087
  • 相关基金:This work was supported by the National Natural Science Foundation of China (No. 30200342, 30672466), the National Basic Research Development Program of China (No. 2006CB503806) and the Special Fund for Promotion of Education, Ministry of Education of China.
中文摘要:

为了验证心脏腺苷酸活化蛋白激酶(AMP-activated protein kinase,AMPK)是否为肾上腺素受体(adrenergic receptor,AR)的下游信号分子,本实验在大鼠心室肌源细胞和大鼠心脏中观察了α-AR对AMPK的激活作用,利用Western blot检测了AMPK-α总蛋白表达量及其172位苏氨酸磷酸化水平。雄性Sprague-Dawley大鼠皮下植入去甲肾上腺素(norepinephrine,NE),苯肾上腺素(phenylephrine,PE)或者溶剂载体[0.01%(W/V)维生素C]的缓释微泵(osmotic minipump)。NE或PE以每小时0.2 mg/kg的速率持续输注,7 d后用AMPK-α抗体免疫沉淀处理样本并测定AMPK的活性。结果显示,在细胞水平,NE引起的AMPK磷酸化水平增高具有时间依赖和剂量依赖特点, NE处理细胞10 min后AMPK磷酸化水平达到最高峰;NE引起的这种效应对β-AR的拮抗剂普萘洛尔(propranolol)不敏感,但是可以被α1-AR拮抗剂哌唑嗪(prazosin)所阻断。结果提示,α1-AR介导AMPK的磷酸化,但β-AR无此作用。AR激动剂持续灌注7 d后,AMPK的活性在NE(7.4倍)和PE(6.0倍)灌注组较对照组显著增高(P〈0.05,H=6)。PE持续灌注组大鼠与对照组相比无明显的心肌肥厚和组织纤维化变化。本文证明α1-AR激动剂可以增强AMPK的活性,揭示了心脏中α1-AR激动在调控AMPK活性方面的重要作用。深入了解α1-AR介导的AMPK激活可能在心衰治疗中具有重要的临床意义。

英文摘要:

To test the hypothesis that AMP-activated protein kinase (AMPK) is possibly the downstream signaling molecule of certain subtypes of adrenergic receptor (AR) in the heart, we evaluated AMPK activation mediated by ARs in H9C2 cells, a rat cardiac source cell line, and rat hearts. The AMPK-α subunit and the phosphorylation level of Thr^172-AMPK-α subunit were subjected to Western blot analysis. Osmotic minipumps filled with norepinephrine (NE), phenylephrine (PE) or vehicle [0.01% (W/V) vitamin C solution] were implanted into male Sprague-Dawley rats subcutaneously. The pumps delivered NE or PE continuously at the rate of 0.2 mg/kg per hour. After 7-day infusion, the activity of AMPK was examined following immunoprecipitation with anti-AMPK-α antibody. At the cellular level, we found that NE elevated AMPK phosphorylation level in a dose- and time-dependent manner, with the maximal effect at 10 gmol/L NE after 10-minute treatment. This effect was insensitive to propranolol, a specific 13-AR antagonist, but abolished by prazosin, an α1-AR antagonist, suggesting that α1-AR but not β-AR mediated the phosphorylation of AMPK. Moreover, the results from rat models of 7-day-infusion of AR agonists demonstrated that the activity of AMPK was significantly higher in NE (7.4-fold) and PE (6.0-fold) infusion groups than that in the vehicle group (P〈0.05, n=6). On the other hand, no obvious cardiac hypertrophy and tissue fibrosis changes were observed in PE-infused ratg. Taken together, our results demonstrate that α1-AR stimulation enhances the activity of AMPK, indicating an important role of afAR stimulation in the regulation of AMPK in the heart. Understanding the activation of AMPK mediated by α1-AR might have clinical implications in the therapy of heart failure.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《生理学报》
  • 中国科技核心期刊
  • 主管单位:中国科学院
  • 主办单位:中国生理学会 中国科学院上海生理研究所
  • 主编:王建军
  • 地址:上海岳阳路319号31B楼
  • 邮编:200031
  • 邮箱:actaps@sibs.ac.cn
  • 电话:021-54922832
  • 国际标准刊号:ISSN:0371-0874
  • 国内统一刊号:ISSN:31-1352/Q
  • 邮发代号:4-157
  • 获奖情况:
  • 中国自然科学核心期刊,中国科学院优秀期刊特别奖,荣获首届国家期刊奖
  • 国内外数据库收录:
  • 美国化学文摘(网络版),波兰哥白尼索引,荷兰文摘与引文数据库,美国生物医学检索系统,美国生物科学数据库,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:8098